Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest update is out from Outset Medical ( (OM) ).
Outset Medical has announced a $169 million private placement financing and a new debt facility of up to $125 million, aiming to retire prior debt and bolster its financial position. This strategic move is expected to support Outset in reaching cashflow breakeven, enabling the company to focus on advancing its mission to transform dialysis delivery, with projected financial improvements and operational growth.
More about Outset Medical
Outset Medical, Inc. is a medical technology company that has pioneered a first-of-its-kind technology aimed at reducing the cost and complexity of dialysis. Their primary product, the Tablo® Hemodialysis System, is FDA-cleared for use in various settings, from hospitals to homes. It provides a comprehensive solution for dialysis treatment, integrating water purification, on-demand dialysate production, and data analytics, thus transforming the dialysis experience for patients and simplifying operations for providers.
YTD Price Performance: 19.66%
Average Trading Volume: 768,661
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $73.56M
Learn more about OM stock on TipRanks’ Stock Analysis page.
Trending Articles
- Don’t Miss Out! Class Action Lawsuit Against Chipotle Mexican Grill (CMG)
- Sticky Mortgage Rates a Boon for Arrived’s Fractional Home Ownership Structure
- 3 Penny Stocks to Watch Now, 1/7/25
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
